# Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal

> **NCT01854632** · PHASE3 · COMPLETED · sponsor: **PATH** · enrollment: 1761 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** SIIL Live Attenuated Influenza Vaccine
- **BIOLOGICAL:** Matched placebo

## Key facts

- **NCT ID:** NCT01854632
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 1761 (ACTUAL)
- **Last updated:** 2015-06-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854632, "Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01854632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*